# Omalizumab in the Treatment of Peanut Allergy

> **NCT00949078** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 51 (actual)

## Conditions studied

- Food Allergy
- Peanut Allergy

## Interventions

- **DRUG:** omalizumab

## Key facts

- **NCT ID:** NCT00949078
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949078, "Omalizumab in the Treatment of Peanut Allergy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00949078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*